Antimicrobial resistance could kill 39 million people over 25 years: WHO
Antimicrobial resistance, or AMR, is when germs no longer respond to medicines used to treat infections. That can make infections harder to treat. The WHO warns that growing resistance threatens the future of modern medicine. The article does not give a formal definition, so this is the established general meaning of AMR. Antibiotic resistance is specifically resistance to antibiotics, which are medicines used against bacterial infections. AMR is broader: it can also refer to resistance to other kinds of antimicrobial medicines, such as those used against viruses, fungi, or parasites. These are different types of germs and medicines, but resistance presents the shared problem of treatments working less well. The WHO official quoted in the article makes this distinction directly: antibiotic resistance is part of the wider AMR issue. The article reports that one in six laboratory-confirmed bacterial infections flagged to WHO in 2023 resisted the antibiotics used to treat it. It also warns that resistance across antimicrobial medicines threatens routine care.
What is antimicrobial resistance, and how is it broader than antibiotic resistance?
Antimicrobial resistance, or AMR, is when germs no longer respond to medicines used to treat infections. That can make infections harder to treat. The WHO warns that growing resistance threatens the future of modern medicine. The article does not give a formal definition, so this is the established general meaning of AMR.
Antibiotic resistance is specifically resistance to antibiotics, which are medicines used against bacterial infections. AMR is broader: it can also refer to resistance to other kinds of antimicrobial medicines, such as those used against viruses, fungi, or parasites. These are different types of germs and medicines, but resistance presents the shared problem of treatments working less well.
The WHO official quoted in the article makes this distinction directly: antibiotic resistance is part of the wider AMR issue. The article reports that one in six laboratory-confirmed bacterial infections flagged to WHO in 2023 resisted the antibiotics used to treat it. It also warns that resistance across antimicrobial medicines threatens routine care.
How large is the toll WHO describes, both in its projection of 39 million deaths and in the reported 2021 figures?
The WHO warns that antimicrobial resistance could cause 39 million deaths over the next 25 years. That projection shows the potential scale of a problem the agency says threatens the future of modern medicine. The article does not provide details about how the projection was calculated, but it links the risk to growing resistance to antibiotics and other medicines.
The reported toll was already large in 2021: AMR was directly responsible for more than one million deaths and linked to about 4.7 million others, according to WHO figures. “Linked to” is not the same as saying resistance directly caused every one of those deaths. The article distinguishes the directly responsible figure from the larger number of associated deaths.
Other figures point to the problem’s reach. In 2023, one in every six laboratory-confirmed bacterial infections flagged to WHO was resistant to the antibiotic used against it. WHO officials say prevention, diagnosis, and appropriate medicine use need to progress faster to meet global targets.
Why can drug-resistant infections make routine surgery and childbirth more dangerous?
Antimicrobial resistance means medicines may not work against infections they are meant to treat. That matters during surgery and childbirth, when infections can pose serious risks and clinicians may need effective medicines. The WHO warns that growing resistance could make routine surgery and childbirth life-threatening. The article does not spell out the medical steps behind that danger.
As general medical context, antibiotics are often used to prevent or treat bacterial infections around operations and childbirth. If bacteria resist the available antibiotics, those medicines may fail to control an infection, leaving fewer effective treatment options. This is why resistance can make otherwise routine care more hazardous; it does not mean every operation or birth will become unsafe.
The WHO says AMR could cause 39 million deaths over the next 25 years. It also reports that in 2023 one in six laboratory-confirmed bacterial infections flagged to the agency resisted the antibiotic used to treat it. The agency identifies infection prevention, vaccination, water and sanitation, and appropriate antimicrobial use as key ways to combat the problem.
How do laboratory tests help clinicians identify an infection and choose a medicine that can treat it?
Laboratory tests can help clinicians identify the pathogen causing an infection and check whether it is susceptible to particular antibiotics. That information matters because the wrong medicine may not treat the infection. WHO surveillance head Sylvia Bertagnolo warned that without testing, clinicians must treat without knowing the cause or which antibiotic will work.
The article describes two WHO tools intended to strengthen countries’ diagnostic capabilities. One sets out which tests should be available at each level of healthcare, from primary care centres to referral hospitals. The other brings together 73 laboratory procedures, including sample collection, pathogen identification, and antibiotic susceptibility testing. Together, these tools cover steps from gathering a sample to finding out which medicines may work.
The need is pressing: WHO’s latest global surveillance data show that in 2023, one in every six laboratory-confirmed bacterial infections flagged to the agency resisted the antibiotic used to treat it. Better testing can give clinicians information to guide treatment. The WHO says faster progress in diagnosis is needed to reach global targets by 2030.
Why is a national action plan not enough unless it is funded, carried out, and monitored?
A national action plan sets out a country’s response to antimicrobial resistance, but its existence does not show that the response is being put into practice. WHO’s review of 183 countries found that nearly nine in 10 had a plan. Yet only 42 countries—less than one in five—had a plan that was financed, implemented, and monitored.
Those three conditions matter because funding supports the work, implementation puts planned measures into effect, and monitoring helps track progress. The article does not detail the barriers individual countries face, but its figures show a clear gap between having a plan and meeting all three conditions. A written commitment alone cannot demonstrate that action is happening or whether it is advancing.
The share of countries with plans has grown from about four in 10 in 2017 to nearly nine in 10 this year. Even so, WHO technical officer Pravasha Prakash said progress needs to speed up to reach the 2030 targets. The figures suggest that making plans workable and tracking their delivery remain important challenges.
Which measures can help slow antimicrobial resistance, from infection prevention to appropriate medicine use?
Antimicrobial resistance is a growing threat, and the WHO identifies several measures to combat it. They include preventing infections, vaccination, better access to water and sanitation, and appropriate use of antimicrobials. The article describes these as the main levers, rather than presenting a single solution.
These measures address different parts of the problem. Preventing infections and vaccination can help reduce infections, while improved water and sanitation are also listed by WHO as measures to combat AMR. Appropriate use of antimicrobials matters because the article highlights the need for appropriate antibiotic use and says progress on it remains too slow. The article does not provide detailed instructions for applying each measure.
The need for action is underscored by WHO’s figures: in 2021, AMR was directly responsible for more than one million deaths and linked to about 4.7 million others. The agency says progress in prevention, diagnosis, and appropriate antibiotic use must speed up to meet global targets. Its two new diagnostic tools are also intended to help countries strengthen testing capabilities.
How do antibiotics work, and how can bacteria evolve resistance to them?
Antibiotics are medicines used to treat bacterial infections. They work by targeting parts or processes of bacteria that are needed for their survival or growth. This differs from treating infections caused by viruses, which antibiotics do not treat. The article discusses antibiotic resistance but does not explain how antibiotics work or how resistance arises.
As established scientific background, bacteria can gain resistance through genetic changes or by acquiring resistance genes from other bacteria. Some changes can make a medicine less able to reach or affect its target. When antibiotics are used, susceptible bacteria may be killed or held back while resistant bacteria survive and multiply. The bacteria do not make a conscious choice to resist.
Over time, resistant bacteria can become more common, so an antibiotic that once worked may no longer treat an infection. The WHO reports that one in six laboratory-confirmed bacterial infections flagged to it in 2023 resisted the antibiotic used to treat it. The agency recommends appropriate antimicrobial use, alongside prevention, vaccination, and better water and sanitation, to combat AMR.
This brief was written by AI from the original reporting and checked by other models. Names, figures and quotes come from the source; read it for full context.
Read more in the JupiteX app
Pulse is free. New stories every 4 hours, each one broken into the questions that explain it.
Or read more news on the web